A spurt in demand for the latest passenger jets helped Boeing (BA) extend the lead over its European rival Airbus in the early part of the year. As a further indication of the ongoing race for market supremacy between the world’s largest aircraft makers, Boeing and Airbus recently forged tie-ups with Embraer and Bombardier respectively to ramp up their portfolios.
The impressive performance on the order front in the first half is anticipated to reflect in Boeing’s second-quarter revenue, which is scheduled to be announced on July 25. Media reports Tuesday revealed that Boeing received a total of 460 new orders in the first six months of 2018, more than double the number of orders booked by Airbus during the same period.
RELATED: Boeing, Embraer forge tie-up
The company also registered a marked increase in deliveries in the first half, primarily owing to strong demand for the 737 and 787 jet models. Total deliveries increased 7.4% annually to 378 units during the period, when the production of the 737 narrow-body model was raised. There was a similar increase in the delivery of Dreamliner, while the 777 witnessed a sharp fall. In the second quarter, the company delivered 194 aircraft, up 6% compared to last year.
The impressive performance on the order front in the first half is anticipated to reflect in Boeing’s second-quarter revenue
According to reports, Boeing is planning to raise the monthly output of 737s by 10% to 52 units in the second half, and further to 57 units in 2019. As per the current estimates, the Chicago-based company will beat Airbus in aircraft deliveries for the sixth consecutive year in 2018.
RELATED: Boeing plans hypersonic aircraft
In the run-up to the Farnborough Airshow to be held in the UK next week, Boeing has already clinched some major deals, including an $8.8-billion order for 75 jets from India-based aviation firm Jet Airways, a $5.6-billion order from Bamboo Airways of Vietnam and a high-value contract from FedEx (FDX) for the supply of 24 freighters.
The Boeing stock has been on a roller-coaster ride in recent months, gaining nearly 17% since the beginning of the year and hitting an all-time high in June. The stock traded higher throughout Tuesday and was up 1.5% at the close, maintaining the uptrend that began last week.
Most Popular
Everything you need to know about Aktis Oncology’s upcoming IPO
IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the
Constellation Brands set to report Q3 2026 earnings. Here’s what to expect
Constellation Brands' (NYSE: STZ) performance across its portfolio has been under scrutiny recently as it navigates a challenging consumer environment marked by sluggish demand and competitive pressures. With the beer
Broadcom Stock: Valuation and margins under review amid AI tailwinds
Broadcom, Inc. (NASDAQ: AVGO) has emerged as a key AI infrastructure supplier, leveraging its expertise in custom AI accelerators, to expand beyond its legacy smartphone and storage chip businesses. However,
